Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC
Geneva, Switzerland (PRWEB) June 01, 2011 Selexis SA, a Swiss-based biotechnology company with technologies for the rapid development and engineering of high yield and stable mammalian cell lines for therapeutic protein manufacturing of recombinant drugs announced today representatives from the Company will be participating in the 2011 BIO International Convention?s One-on-One Partnering Meetings being held … Read more